.Pharmacolibrary.Drugs.V_Various.V10X_OtherTherapeuticRadiopharmaceuticals.V10XX01_SodiumPhosphate32p.SodiumPhosphate32p .Pharmacolibrary.Drugs.V_Various.V10X_OtherTherapeuticRadiopharmaceuticals.V10XX01_SodiumPhosphate32p.SodiumPhosphate32p| name: | SodiumPhosphate32p |
| ATC code: | V10XX01 | route: | intravenous |
| n-compartments | 1 |
Sodium phosphate (32P) is a radiopharmaceutical used in the treatment of certain blood disorders and cancers, such as polycythemia vera and chronic leukemia. It is a beta-emitting radioactive isotope, formerly used for palliative and therapeutic purposes. Its clinical use has declined significantly due to newer therapies and its serious side effect profile.
No direct human pharmacokinetic data or parameter values published in peer-reviewed literature for sodium phosphate (32P) could be found. Below are estimated pharmacokinetic parameters based on typical behavior of inorganic phosphate and radiopharmaceutical distribution in adults.